Total Payments
$3,313
2024 Payments
$963.68
Companies
18
Transactions
151
Medicare Patients
1,190
Medicare Billing
$61,540
Payment Breakdown by Category
Food & Beverage$3,049 (92.0%)
Education$264.47 (8.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,049 | 146 | 92.0% |
| Education | $264.47 | 5 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $655.49 | 44 | $0 (2024) |
| Galderma Laboratories, L.P. | $403.57 | 8 | $0 (2023) |
| Dermavant Sciences, Inc. | $365.00 | 33 | $0 (2024) |
| Incyte Corporation | $359.60 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $316.54 | 8 | $0 (2024) |
| UCB, Inc. | $256.43 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $239.98 | 12 | $0 (2024) |
| PFIZER INC. | $130.82 | 6 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $126.88 | 5 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $121.57 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $963.68 | 44 | UCB, Inc. ($224.67) |
| 2023 | $1,104 | 52 | Dermavant Sciences, Inc. ($227.76) |
| 2022 | $737.95 | 34 | ABBVIE INC. ($232.60) |
| 2021 | $507.83 | 21 | Galderma Laboratories, L.P. ($245.60) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.67 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.10 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: DERMATOLOGY | ||||||
| 09/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Dermatology | ||||||
| 09/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: DERMATOLOGY | ||||||
| 07/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: DERMATOLOGY | ||||||
| 07/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: DERMATOLOGY | ||||||
| 06/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $66.93 | General |
| Category: Dermatology | ||||||
| 06/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: DERMATOLOGY | ||||||
| 06/02/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $54.99 | General |
| 06/01/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $93.05 | General |
| Category: Dermatology | ||||||
| 06/01/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $45.84 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 375 | 760 | $93,112 | $18,062 |
| 2022 | 12 | 501 | 840 | $118,047 | $26,492 |
| 2021 | 10 | 314 | 515 | $77,607 | $16,987 |
Total Patients
1,190
Total Services
2,115
Medicare Billing
$61,540
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 148 | $31,968 | $6,447 | 20.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 72 | 100 | $15,600 | $2,835 | 18.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 32 | $9,824 | $2,053 | 20.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 34 | 36 | $8,820 | $1,728 | 19.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 54 | 337 | $5,055 | $1,216 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 28 | 28 | $7,420 | $1,188 | 16.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 20 | 23 | $6,141 | $1,174 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,764 | $769.72 | 16.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 11 | 11 | $3,355 | $626.40 | 18.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 33 | $165.00 | $24.01 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 118 | $25,488 | $6,008 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 76 | 76 | $20,140 | $4,023 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $13,498 | $2,949 | 21.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 76 | 89 | $13,884 | $2,795 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 33 | $10,131 | $2,522 | 24.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 32 | 32 | $9,760 | $2,282 | 23.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 37 | 37 | $9,879 | $2,123 | 21.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 26 | 28 | $6,860 | $1,606 | 23.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 61 | 337 | $5,055 | $1,412 | 27.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 11 | 13 | $1,729 | $456.54 | 26.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 11 | 11 | $1,463 | $289.62 | 19.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 32 | $160.00 | $25.76 | 16.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 64 | 64 | $16,940 | $3,450 | 20.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 53 | $11,448 | $2,846 | 24.9% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 34 | 35 | $10,660 | $2,590 | 24.3% |
About Emily Erickson, PA-C
Emily Erickson, PA-C is a Medical healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1376776898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Erickson, PA-C has received a total of $3,313 in payments from pharmaceutical and medical device companies, with $963.68 received in 2024. These payments were reported across 151 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,049).
As a Medicare-enrolled provider, Erickson has provided services to 1,190 Medicare beneficiaries, totaling 2,115 services with total Medicare billing of $61,540. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Des Moines, IA
- Active Since 09/01/2009
- Last Updated 01/27/2010
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1376776898
Products in Payments
- SKYRIZI (Biological) $509.70
- VTAMA (Drug) $365.00
- OPZELURA (Drug) $359.60
- TREMFYA (Drug) $316.54
- AKLIEF (Drug) $267.26
- Bimzelx (Biological) $169.68
- EPSOLAY (Drug) $136.31
- COSENTYX (Drug) $107.43
- TALTZ (Drug) $100.98
- Winlevi (Drug) $92.63
- Cabtreo (Drug) $81.07
- CIBINQO (Drug) $75.25
- HUMIRA (Biological) $59.28
- RINVOQ (Biological) $58.81
- EUCRISA (Drug) $55.57
- DUPIXENT (Biological) $46.50
- JUBLIA (Drug) $45.81
- Otezla (Drug) $37.33
- COSENTYX (Biological) $36.74
- QBREXZA (Drug) $34.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Des Moines
Sarah Lochman, Pa, PA
Medical — Payments: $860.19
Medical $860.19
Sharon Johnson, P.a, P.A
Medical — Payments: $590.16
Medical $590.16
Mrs. Jamie Schumacher, Pa-C, PA-C
Medical — Payments: $506.89
Medical $506.89
Ms. Jessica Mathisen, Pa-C, PA-C
Medical — Payments: $343.84
Medical $343.84
Stacy Van Heeswyk, Pa-C, PA-C
Medical — Payments: $167.50
Medical $167.50
Dr. Pedro Febo Toledo, Md, MD
Medical — Payments: $156.89
Medical $156.89